Kalaris Therapeutics Inc
NASDAQ:KLRSBiotechnology
+$0.16 today
- Market cap
- $54.75M
- Beta
- 0.14
- P/E (TTM)
- -2.5
- EPS (TTM)
- -$1.86
Volume 0.07M
Average 0.08M
Fair Value & DCF
Compare our fair value with your own assumptions
Intrinsic Alpha selects a valuation method suited to the business. Use the calculator below to build an independent scenario with your preferred cash-flow basis.
Kalaris Therapeutics Inc
NASDAQ:KLRS
Intrinsic Alpha fair value
Locked
Current Price
$2.30
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Build your own valuation
Test an independent scenario and compare it with Intrinsic Alpha's estimate.
Sign in to use the DCF calculator
Free accounts get 5 valuations per week. Upgrade for more.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A2 analysts |
| Revenue | N/A | N/A | N/A | N/A3 analysts |
| Net Income | N/A | N/A | N/A | N/A3 analysts |
| EBIT | N/A | N/A | N/A | N/A3 analysts |
Analysis
Analysis will appear once historical growth or forward estimates are available for this company.
Estimates & History
Historical data and analyst estimates. Solid bars are actuals; dashed-border bars are future estimates.
Competitor Valuations
Peer stocks ranked by intrinsic value status
| Company | Market Cap | Price | Valuation | P/E | 1Y Return |
|---|---|---|---|---|---|
Ovid Therapeutics Inc. NASDAQ:OVID | $556.60M | $2.85 | Not rated | -7.1 | +91.80% |
Shattuck Labs, Inc. NASDAQ:STTK | $463.68M | $4.62 | Not rated | -10.9 | +135.75% |
Artiva Biotherapeutics, Inc. NASDAQ:ARTV | $202.89M | $4.15 | Not rated | -2.7 | +20.82% |
InflaRx N.V. NASDAQ:IFRX | $192.32M | $1.31 | Not rated | -2.7 | -5.22% |
Sutro Biopharma, Inc. NASDAQ:STRO | $159.51M | $9.62 | Not rated | -0.0 | +2.95% |
ImageneBio Inc NASDAQ:IMA | $46.60M | $4.11 | Not rated | -1.5 | -35.52% |
Connect Biopharma Holdings Limited NASDAQ:CNTB | $45.89M | $0.73 | Not rated | -4.0 | -74.53% |
Context Therapeutics Inc. NASDAQ:CNTX | $17.78M | $0.19 | Not rated | -1.5 | -39.21% |
Continue the stock analysis
Jump to another research area for this company.